Aptorum Group Ltd
NASDAQ:APM

Watchlist Manager
Aptorum Group Ltd Logo
Aptorum Group Ltd
NASDAQ:APM
Watchlist
Price: 1.25 USD -3.85%
Market Cap: 10.2m USD

Relative Value

There is not enough data to reliably calculate the relative value of APM.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

APM Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
23
Median 3Y
11.3
Median 5Y
30.8
Industry
7.9
Forward
0.1
vs History
vs Industry
0
Median 3Y
-2.2
Median 5Y
-2.8
Industry
23.7
Forward
0
vs History
vs Industry
Median 3Y
-4.8
Median 5Y
-7.7
Industry
22
vs History
vs Industry
6
Median 3Y
-4.1
Median 5Y
-7.1
Industry
23.8
vs History
85
vs Industry
75
Median 3Y
0.8
Median 5Y
1.6
Industry
3.3
vs History
vs Industry
19
Median 3Y
11.1
Median 5Y
32.9
Industry
8.3
Forward
0.1
vs History
vs Industry
1
Median 3Y
328.6
Median 5Y
557.5
Industry
10.1
vs History
vs Industry
Median 3Y
-3.1
Median 5Y
-5.7
Industry
6.4
Forward
0.7
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-5
Industry
7
Forward
0.1
vs History
vs Industry
Median 3Y
-5.2
Median 5Y
-7.3
Industry
8.3
vs History
vs Industry
Median 3Y
-5.2
Median 5Y
-7.3
Industry
6.5
vs History
84
vs Industry
63
Median 3Y
1.2
Median 5Y
2.3
Industry
5.7

Multiples Across Competitors

APM Competitors Multiples
Aptorum Group Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Aptorum Group Ltd
NASDAQ:APM
10.2m USD 0 -2.4 -5.4 -4.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 738 486.8 -160 354 -194 720.9 -192 498.9
US
Abbvie Inc
NYSE:ABBV
396.8B USD 6.7 168.8 16.4 23.2
US
Amgen Inc
NASDAQ:AMGN
174B USD 4.8 25 18 18
US
Gilead Sciences Inc
NASDAQ:GILD
150.7B USD 5.2 18.5 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.3B USD 9.9 31.4 23 24
US
Epizyme Inc
F:EPE
94.1B EUR 2 088.1 -532.8 -580.2 -564.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79B USD 5.5 17.2 16.4 18.6
AU
CSL Ltd
ASX:CSL
85.8B AUD 3.7 19 12.8 16
NL
argenx SE
XBRU:ARGX
44.1B EUR 14.4 33.8 58.3 59.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
51.6B USD 16.1 1 191.4 155.5 188.6
P/S Multiple
Revenue Growth P/S to Growth
UK
Aptorum Group Ltd
NASDAQ:APM
Average P/S: 3 374 064.1
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 738 486.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.7
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.8
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.2
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.9
10%
1
US
E
Epizyme Inc
F:EPE
2 088.1
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.5
6%
0.9
AU
CSL Ltd
ASX:CSL
3.7
5%
0.7
NL
argenx SE
XBRU:ARGX
14.4
49%
0.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.1
46%
0.4
P/E Multiple
Earnings Growth PEG
UK
Aptorum Group Ltd
NASDAQ:APM
Average P/E: 188.2
Negative Multiple: -2.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 354 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168.8
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.5
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.4
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.2
9%
1.9
AU
CSL Ltd
ASX:CSL
19
11%
1.7
NL
argenx SE
XBRU:ARGX
33.8
40%
0.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 191.4
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Aptorum Group Ltd
NASDAQ:APM
Average EV/EBITDA: 39.1
Negative Multiple: -5.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 720.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.4
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -580.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.4
11%
1.5
AU
CSL Ltd
ASX:CSL
12.8
8%
1.6
NL
argenx SE
XBRU:ARGX
58.3
839%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
155.5
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
Aptorum Group Ltd
NASDAQ:APM
Average EV/EBIT: 45.1
Negative Multiple: -4.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 498.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.2
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -564.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.6
13%
1.4
AU
CSL Ltd
ASX:CSL
16
11%
1.5
NL
argenx SE
XBRU:ARGX
59.9
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
188.6
N/A N/A